336 related articles for article (PubMed ID: 23002981)
1. Vaccination against influenza: role and limitations in pandemic intervention plans.
Rebmann T; Zelicoff A
Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
[TBL] [Abstract][Full Text] [Related]
2. A note on the use of influenza vaccination strategies when supply is limited.
Lee S; Morales R; Castillo-Chavez C
Math Biosci Eng; 2011 Jan; 8(1):171-82. PubMed ID: 21361406
[TBL] [Abstract][Full Text] [Related]
3. Uptake of pandemic influenza (H1N1)-2009 vaccines in Brazil, 2010.
Domingues CM; de Oliveira WK;
Vaccine; 2012 Jul; 30(32):4744-51. PubMed ID: 22609010
[TBL] [Abstract][Full Text] [Related]
4. Acceptance of a vaccine against pandemic influenza A (H1N1) virus amongst healthcare workers in Beijing, China.
Seale H; Kaur R; Wang Q; Yang P; Zhang Y; Wang X; Li X; Zhang H; Zhang Z; MacIntyre CR
Vaccine; 2011 Feb; 29(8):1605-10. PubMed ID: 21211593
[TBL] [Abstract][Full Text] [Related]
5. Pandemic influenza A (H1N1) 2009 vaccine: an update.
Goel MK; Goel M; Khanna P; Mittal K
Indian J Med Microbiol; 2011; 29(1):13-8. PubMed ID: 21304188
[TBL] [Abstract][Full Text] [Related]
6. The development of vaccine viruses against pandemic A(H1N1) influenza.
Robertson JS; Nicolson C; Harvey R; Johnson R; Major D; Guilfoyle K; Roseby S; Newman R; Collin R; Wallis C; Engelhardt OG; Wood JM; Le J; Manojkumar R; Pokorny BA; Silverman J; Devis R; Bucher D; Verity E; Agius C; Camuglia S; Ong C; Rockman S; Curtis A; Schoofs P; Zoueva O; Xie H; Li X; Lin Z; Ye Z; Chen LM; O'Neill E; Balish A; Lipatov AS; Guo Z; Isakova I; Davis CT; Rivailler P; Gustin KM; Belser JA; Maines TR; Tumpey TM; Xu X; Katz JM; Klimov A; Cox NJ; Donis RO
Vaccine; 2011 Feb; 29(9):1836-43. PubMed ID: 21199698
[TBL] [Abstract][Full Text] [Related]
7. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
Abelin A; Colegate T; Gardner S; Hehme N; Palache A
Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
[TBL] [Abstract][Full Text] [Related]
8. Pandemic influenza A (H1N1) 2009 in a critical care and theatre setting: beliefs and attitudes towards staff vaccination.
Parry HM; Damery S; Fergusson A; Draper H; Bion J; Low AE
J Hosp Infect; 2011 Aug; 78(4):302-7. PubMed ID: 21481491
[TBL] [Abstract][Full Text] [Related]
9. PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries.
Neuzil KM; Tsvetnitsky V; Nyari LJ; Bright RA; Boslego JW;
Expert Rev Vaccines; 2012 Aug; 11(8):939-47. PubMed ID: 23002975
[TBL] [Abstract][Full Text] [Related]
10. [Pandemic vaccines].
Floret D
Arch Pediatr; 2010 Jun; 17(6):906-7. PubMed ID: 20654954
[No Abstract] [Full Text] [Related]
11. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M
Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549
[TBL] [Abstract][Full Text] [Related]
12. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
13. Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: addressing the threat of an influenza pandemic.
Surichan S; Wirachwong P; Supachaturas W; Utid K; Theerasurakarn S; Langsanam P; Lakornrach P; Nitisaporn L; Chansikkakorn C; Vangkanonta W; Kaweepornpoj R; Poopipatpol K; Thirapakpoomanunt S; Srichainak S; Artavatkun W; Chokevivat V; Wibulpolprasert S
Vaccine; 2011 Jul; 29 Suppl 1():A29-33. PubMed ID: 21684425
[TBL] [Abstract][Full Text] [Related]
14. Awareness of the background rate of sudden cardiac death during mass immunization with pandemic H1N1 influenza vaccines increases the intended vaccination rate.
Wang Y; Xiao Z; Wang W
Prev Med; 2010 Nov; 51(5):445-6. PubMed ID: 20832419
[No Abstract] [Full Text] [Related]
15. Evaluation of vaccination strategies during pandemic outbreaks.
Bowman CS; Arino J; Moghadas SM
Math Biosci Eng; 2011 Jan; 8(1):113-22. PubMed ID: 21361403
[TBL] [Abstract][Full Text] [Related]
16. System factors to explain H1N1 state vaccination rates for adults in US emergency response to pandemic.
Davila-Payan C; Swann J; Wortley PM
Vaccine; 2014 May; 32(25):3088-93. PubMed ID: 23727421
[TBL] [Abstract][Full Text] [Related]
17. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
Choo AY; Broderick KE; Kim JJ; Sardesai NY
IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
[TBL] [Abstract][Full Text] [Related]
18. A pandemic influenza vaccine in India: from strain to sale within 12 months.
Dhere R; Yeolekar L; Kulkarni P; Menon R; Vaidya V; Ganguly M; Tyagi P; Barde P; Jadhav S
Vaccine; 2011 Jul; 29 Suppl 1():A16-21. PubMed ID: 21684421
[TBL] [Abstract][Full Text] [Related]
19. [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel].
Ormen B; Türker N; Vardar I; Kaptan F; El S; Ural S; Kaya F; Coşkun NA
Mikrobiyol Bul; 2012 Jan; 46(1):57-64. PubMed ID: 22399172
[TBL] [Abstract][Full Text] [Related]
20. Japan's immunisation policy in routine, pandemic and post-tsunami situations.
Murashige N
Int J Clin Pract; 2011 Nov; 65(11):1126-31. PubMed ID: 21995691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
